ARRZX
Price
$13.12
Change
-$0.08 (-0.61%)
Updated
Jul 31 closing price
Net Assets
45.54M
VEXMX
Price
$179.20
Change
-$0.73 (-0.41%)
Updated
Jul 31 closing price
Net Assets
97.68B
Interact to see
Advertisement

ARRZX vs VEXMX

ARRZX vs VEXMX Comparison Chart in %
View a ticker or compare two or three
VS
ARRZX vs. VEXMX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRZX is a Hold and VEXMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 97.7B vs. ARRZX (45.5M). ARRZX pays higher dividends than VEXMX: ARRZX (1.02) vs VEXMX (0.90). ARRZX was incepted earlier than VEXMX: ARRZX (9 years) vs VEXMX (39 years). ARRZX (0.97) is less costly to investors than VEXMX (0.19). ARRZX is a more actively managed with annual turnover of: 92.00 vs. VEXMX (12.00). VEXMX has a lower initial minimum investment than ARRZX: VEXMX (3000) vs ARRZX (5000000). VEXMX annual gain was more profitable for investors over the last year : 19.71 vs. ARRZX (-4.38). VEXMX return over 5 years is better than : 28.12 vs. ARRZX (-9.66).
ARRZXVEXMXARRZX / VEXMX
Total Expense Ratio0.780.19411%
Annual Report Gross Expense Ratio0.970.19511%
Fund Existence9 years39 years-
Gain YTD0.38313.0333%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets45.5M97.7B0%
Annual Yield % from dividends1.020.90113%
Returns for 1 year-4.3819.71-22%
Returns for 3 years6.1551.7512%
Returns for 5 years-9.6628.12-34%
Returns for 10 yearsN/A174.92-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEMMX56.551.15
+2.08%
Fidelity Advisor Emerging Markets C
FFBFX31.340.12
+0.38%
Emerald Bkg & Finac Evolution - Inv
JGLYX21.55-0.01
-0.05%
JPMorgan Small Cap Growth R4
PQIPX15.59-0.05
-0.32%
PIMCO Dividend and Income I2
BIVRX18.50-0.21
-1.12%
Invenomic Investor